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1. Introduction 
1.1 Cyclic Adenosine Monophosphate (cAMP) metabolism in mycobacteria 
1.1.1 General aspects of Adenylyl Cyclases and their presence in M. tuberculosis 
genomes 
Adelynate cyclases (ACs), which catalyze synthesis of cAMP from ATP and yield 
pyrophosphate as a by-product, can be classified into four different classes according to 
their common features: Class I cyclases, related to enterobacterial adenylate cyclases; Class 
II, toxic adenylate cyclases isolated from bacterial pathogens; Class III, a large and probably 
ancient class that comprises cyclases from both eukaryotes and prokaryotes and is strongly 
related to guanylate cyclases; and Class IV, with mainly one example that differs entirely 
from all other classes (McCue et al., 2000). 
In class I ACs (the enterobacterial type) no long stretch of hydrophobic amino acid residues 
is present to explain the membrane-bound localization of the adenylate cyclases. In all cases, 
the proteins are very rich in cysteine residues, an uncommon feature for proteins located in 
the cytoplasm or at the cytoplasmic border of the membrane. They are also rich in histidine 
residues, which could indicate that metal ions take part in the folding and/or activity of the 
polypeptide chain (Mock et al., 1991). 
Class II ACs (the calmodulin-activated toxic class) is represented by Bordetella pertussis 
adenylate cyclase. It is synthesized as a large bifunctional polypeptide chain of 1706 amino 
acid residues. The N-terminal segment of the protein (400 residues) alone displays 
calmodulin-activated adenylate cyclase activity, whereas the rest of the molecule is 
responsible for hemolytic activity and for transporting the toxin. After attempts to isolate 
other members of this class, several examples of similar proteins have now been discovered 
in Bacillus anthracis, Pseudomonas aeruginosa, and in Yersinia species. Comparison of the 
catalytic regions of the B. pertussis and B. anthracis adenylate cyclases identified four 
conserved regions that are involved in catalysis, calmodulin binding and activation. The 
first region comprises a sequence, Gly-XXXX-Gly(Ala)-Lys-Ser, similar to the nucleotide-
binding motif found in many ATP- or GTP-binding proteins. Analysis of the region 
conserved between the B. anthracis and B. pertussis enzymes, indicates that these proteins 
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may form a catalytic center from the cooperation of two halves. The function of calmodulin 
may be to trigger the appropriate conformational change necessary to form an active 
catalytic center (Drum et al., 2002). 
Class III ACs (the “universal” class) form a very diverse collection of enzymes in eubacteria. 
They comprise two domains: the catalytic domain is carboxy-terminal and the regulatory 
domain is likely an ion transporter in one case and the phosphorylated moiety of a two-
component regulatory system in another. Most mammalian ACs are monomeric integral 
membrane proteins that are catalytically active as pseudoheterodimers (Sunahara et al., 
1996),while prokaryotes and lower eukaryotes produce both soluble and membrane-bound 
nucleotidyl cyclases of variant domain compositions functioning as homodimers (Guo et al., 
2001). In general, class III ACs are the most widespread class of cAMP-generating enzymes, 
and they are further subdivided into four subclasses: IIIa-IIId. Dimerization is required for all 
class III ACs in order to be active, given the substrate-binding sites are formed at the dimer 
interface (Abdel Motaal et al., 2006). Class III adenylyl and guanylyl cyclases are proteins with 
a central four stranded anti-parallel ǃ-sheet structurally similar to the palm domain of DNA 
polymerases, and ǂ-helices on either side (Shenoy & Visweswariah, 2006b). So far, all Cyclase 
Homology Domain (CHDs) proteins operate as dimers with mostly two catalytic centers 
positioned at the dimer interface, where catalysis is based on six highly conserved residues. 
Two aspartate residues coordinate two metal cofactors (Mg2+ or Mn2+), an asparagine and an 
arginine stabilize the transition-state and a lysine-aspartate couple specifies ATP as a substrate. 
Several mycobacterial ACs gene products were early annotated as putative cyclases, but have 
now been characterized biochemically and structurally.  
Class IV ACs was assigned to Aeromonas hydrophila, which synthesizes a very small cyclase 
of 193 residues. This class IV cyclase has an optimal temperature for activity of 65°C and is 
at least ten times more active than the class I adenylate cyclase in the same organism 
(Sismeiro et al., 1998). No function has yet been discovered for this protein. Currently, it has 
been found only in various isolates of A. hydrophila and in Y. pestis. 
Most prokaryotes contain a single adenylate cyclase (AC, e.g. E. coli) and some contain none 
(e.g., Bacillus species); however, 16 or 17 genes have been identified as ACs in mycobacteria, 
and in particular M. tuberculosis. AC enzymes require the presence of conserved metal-, 
substrate-binding (either ATP or GTP) amino acid residues and transition-state stabilizing 
amino acid residues in their catalytic site (Shenoy & Visweswariah, 2006b).  
The genome of M. tuberculosis H37Rv encodes 16 class III cyclases while the CDC1551 strain 
has 17 cyclases. Using the 16 H37Rv class III ACs genes as query, we found they posses 
different numbers of orthologous genes in the up-to-date sequenced mycobacterial genomes 
available at MycoDB (http://xbase.bham.ac.uk/mycodb/, Table 1). This suggests that some 
of these cyclases have more conserved roles than others. Several mycobacterial gene 
products initially classified as cyclases have now been biochemically and structurally 
characterized as ACs. In mycobacteria, they retain similar catalytic properties to the 
mammalian enzymes, in terms of the requirement for divalent cations, and dimerization as a 
prerequisite to generate the catalytic site. 
Bioinformatics analysis has predicted subcellular localization of mycobacterial ACs 
(Shenoy et al., 2004). Nevertheless, experimental studies have identified proteins like 
Rv0386 and Rv1358 in mycobacterial cell wall and membranes, despite the absence of 
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hydrophobic, predicted transmembrane domains (Agarwal, 2009). This suggests that a 
necessary improvement to prediction software must emphasize these particularities of 
mycobacteria. 
Gene name Orthologous (No.)
Rv0386 7
Rv0805 7
RV0891c 4
Rv1264 13
Rv1318c 14
Rv1319c 14
Rv1320c 14
Rv1358 7
Rv1359 3
Rv1625c 11
Rv1647 16
Rv1900c 10
Rv2212 6
Rv2564 3
Rv2565 3
Rv3645 16
 
Table 1. Orthologous to H37Rv AC-domain containing genes present in Mycobacteria 
As mycobacteria lack G-proteins, it is unknown how bacterial adenylate cyclase AC 
activities are modulated. However, polyphosphates isolated from M. bovis BCG were potent 
inhibitors of Rv1625c, Rv1264, and Rv3645, and the mechanism of inhibition proposed is 
that polyphosphates possibly obstructs the catalytic fold of ACs (Guo et al., 2001). 
1.2 cAMP producing (Adenylyl cyclases) and degrading (Phosphodiesterase) 
mycobacterial enzymes 
Six M. tuberculosis AC-domain containing proteins (Rv0891c, Rv1264, Rv1359, Rv1647, 
Rv2212 and Rv1625c) contain just a cyclase domain. Rv1647 and Rv1625c are 
phylogenetically distant and biochemically distinct AC-domain containing proteins (Shenoy 
& Visweswariah, 2006a). The remaining AC-domain containing proteins have additional 
domains that presumably allow them to respond to multiple signals, regulate their activity 
in response to environmental conditions, and/or expand their repertoire with effector 
function capability. Five of these multidomain AC-domain containing proteins (Rv1318c, 
Rv1319c, Rv1320c, Rv2435c and Rv3645c) are membrane-associated and contain HAMP 
(histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins and 
phosphatases) domains. HAMP domains are often associated with two-component signal 
transduction pathways and connect the sensing of extracellular environmental signals with 
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responding intracellular signalling domains. Mycobacterial ACs with HAMP domains have 
six transmembrane regions, followed by the HAMP domain and a C-terminal AC domain. 
Modulators of M. tuberculosis AC activity include pH and fatty acids, which were seen to 
enhance the pH sensitivity of the holoenzyme, and CO2 levels, and could be signals present 
during M. tuberculosis host infection (Abdel Motaal et al., 2006, Bai et al., 2011, Barba et al., 
2010). 
An N-terminal autoregulatory domain in Rv1264 is a pH-response element that inhibits 
cyclase activity above pH 6.0. Additional AC-domain containing proteins (Rv0386, Rv1358 
and Rv2488c) posses both ATPase and helix– turn–helix (HTH) domains. Rv1900c contains 
an -hydrolase domain (Barba et al., 2010, Bai et al., 2011). Rv0386 is the first AC-domain 
containing protein as a representative of the family of putative DNA-binding domain-
containing cyclases in mycobacteria (Castro et al., 2005). Rv0386 has guanylyl cyclase activity 
that is 20% of its adenylyl cyclase activity. 
Rv1625c adenylyl cyclase is particularly unusual, in that it is catalytically active when 
expressed in mammalian cells or in E. coli. The Rv1264 holoenzyme shows higher AC 
activity at acidic pH (pH 6.0). Similarly, the Rv1264 AC is activated only at low pH (pH 
5.5) whereas Rv1647 is active only at high pH (pH 8.5). The localization of Rv1647 in the 
cell wall and membrane fractions of M. tuberculosis might enable the bacteria to sense and 
respond to extracellular pH shifts. Because M. tuberculosis actively avoids phagosomal 
acidification, sensing of pH and bicarbonate and/or CO2 could be crucial signaling events 
in M. tuberculosis pathogenesis (Shenoy & Visweswariah, 2006a). In fact, cAMP production 
in pathogenic mycobacteria increased when the pH of their growth medium was shifted 
from pH 6.7 to pH 5.5 (Gazdik et al., 2009), thus suggesting activation of the acid-
responsive ACs.  
In M. tuberculosis, Rv0998 was recently shown to regulate protein lysine acetylation in a 
cAMP-responsive manner (Nambi et al., 2010), where acetylation is enhanced in the 
presence of either cAMP or cGMP. Recently, it was shown that a cAMP-dependent protein 
acetyltransferase inactivates ACs through acetylation of a single, specific lysine residue,  
and Rv1151c is a NAD+-dependent deacetylase that reactivates ACs. This 
acetylation/deacetylation system in mycobacteria is likely to sense the extracellular 
environment through cAMP levels and also key intracellular metabolites, including NAD+ 
and AcCoA, since cAMP, AcCoA, and NAD+ are required for acetylation and deacetylation, 
respectively (Xu et al., 2011).  
Adenylyl cyclase Rv2212 from M. tuberculosis has a domain composition identical to the pH-
sensing isoform Rv1264, an N-terminal regulatory domain and a C-terminal catalytic 
domain. The maximal velocity of Rv2212 was the highest of all 10 mycobacterial cyclases 
investigated to date. Unsaturated fatty acids strongly stimulated Rv2212c activity by 
increasing substrate affinity (Findeisen et al., 2007). In addition, fatty acids greatly enhanced 
the pH sensitivity of the holoenzyme, thus converting Rv2212c to a pH sensor adenylyl 
cyclase (Abdel Motaal et al., 2006). 
To date, the only identifiable cAMP phosphodiesterase (PDE) in the genome of M. 
tuberculosis H37Rv is the one encoded by the Rv0805 gene. This enzyme is a dimeric Fe(3+)-
Mn(2+) binuclear PDE, where metals coordinated at the catalytic site contribute to 
dimerization and thus play an additional structural role apart from their involvement in 
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catalysis (Shenoy et al., 2007). As this gene is found only in pathogenic mycobacteria, Rv0805 
may therefore play a key role in the pathogenicity of mycobacteria, not only by hydrolyzing 
bacterial cAMP, but also by indicating as a protein that can alter cell wall functioning 
(Podobnik et al., 2009).  
2. Participation of cyclic adenosine 3′,5′-monophosphate (cAMP) in 
mycobacterial gene regulation  
Cyclic adenosine 3′,5′-monophosphate (cAMP) is one of the most important second 
messengers used in bacteria and it has been characterized principally in Escherichia coli. 
However its signaling role in M. tuberculosis is beginning to emerge. A large number of AC 
genes are present in Mycobacterium tuberculosis in comparison with other microorganims 
(Cha et al., 2010, Klengel et al., 2005, Shenoy et al., 2004), and also that Mycobacterium just 
have one class III cNMP phosphodiesterase (Rv0805) that has been identified in M. 
tuberculosis (McCue et al., 2000, Shenoy et al., 2007) with a modest ability to efficiently 
hydrolyse 3′,5′-cAMP and that responds to H2O2 in vitro (Bai et al., 2011, Barba et al., 2010). 
cAMP may serve as both an extra and intracellular signaling molecule in mycobacteria 
(Agarwal, 2009). cAMP levels are modulated by stress conditions in M. smegmatis, where it 
has been found in concentrations between 10 µM and 1 mM, suggesting that cAMP 
participates in signalling events within the bacterial cell, mediating its action by 
downstream effectors (Dass et al., 2008). 
It appears that Mycobacteria need to maintain a steady level of cytoplasmatic cAMP in 
many conditions. For example, it has been shown that cytoplasmic cAMP levels in E. coli are 
reduced three- to fourfold when the carbon source is ~0.2% glucose rather than glycerol (Bai 
et al., 2011). In contrast, a recent study showed no significant change in the cytoplasmic 
cAMP levels of M. bovis BCG incubated with 0.2% glucose (Bai et al., 2009), or carbon-
starved bacteria (Dass et al., 2008). cAMP levels decrease in both fast- and slow-growing 
mycobacteria in response to very high levels of glucose (2%) (Bai et al., 2011). cAMP levels 
have been suggested to be high in Mycobacterium cells, exceeding up to 100-fold levels found 
in other bacteria (Nambi et al., 2010, Stapleton et al., 2010, Shenoy & Visweswariah, 2006b, 
Rickman et al., 2005). However, it is difficult to make a comparison between studies, due to 
cAMP variations presents in the conditions tested, as well as the different normalization and 
reporting methods used.  
2.1 CRP and cNMP binding proteins   
In silico studies predict 10 cNMP binding proteins that encompass a wide range of potential 
effector functions, suggesting a more complex role for cAMP signalling, probably important 
during host infection. From these 10 cNMP binding proteins, 7 (Rv0073, Rv0104, Rv2434c, 
Rv2564, Rv2565, Rv3239c and Rv3728) contain an assortment of putative functional 
domains, including those associated with transport functions and esterase activities (McCue 
et al., 2000, Shenoy & Visweswariah, 2006a). Only three cNMP binding proteins have been 
functionally characterized to date (Bai et al., 2011). Two of these proteins, referred to as CRP 
(Rv3676, for Catabolite Represor Protein) and Cmr (Rv1675c, for cAMP and macrophage 
regulator), contain a HTH DNA binding domains, and belong to the CRP-FNR family of 
transcription factors (McCue et al., 2000). The third protein from this group, is encoded by 
www.intechopen.com
 
Understanding Tuberculosis – Deciphering the Secret Life of the Bacilli 
 
108 
Rv0998 in M. tuberculosis, and regulates lysine acetylation in mycobacterial proteins in a 
cAMP-responsive manner (Nambi et al., 2010). The biological effects of this acetylation are 
not yet defined.   
CRP (cAMP receptor protein) in Escherichia coli, is one of the best-studied prokaryotic 
transcription factor. Currently, a total of 378 target promoters on the Escherichia coli genome 
are proposed to be under the control of cAMP-bound CRP, using a SELEX approach 
(Shimada et al., 2011). Some of the CRP regulon genes include those encoding the 
transporters and the catabolic enzymes of glucose (Perrenoud & Sauer, 2005) and non-
glucose sugars (Wickstrum et al., 2010), virulence genes (Espert et al., 2011), motility genes 
(Hollands et al., 2010), GMP synthesis (Husnain et al., 2009), anaerobic growth and nitrate 
reductases genes (Stewart et al., 2009).  To date, in E. coli, 2 differents ways in which CRP 
leads the sigma 70 promoter trancription have been described: in the Class I promoters, CRP 
binds upstream of the promoter −35 element, at a site centered at position −61.5 or further 
upstream, and an activating region (AR1) in the downstream subunit of the CRP dimer 
makes contact with the C-terminal domain of one of the two RNA polymerase ǂ subunits 
(ǂCTD). In class II promoters, CRP binds at a target that overlaps the promoter −35 element 
and is usually centered at position −41.5. AR1 in the upstream subunit of the CRP dimer 
interacts with ǂCTD, while a second activating region (AR2) in the downstream subunit 
interacts with the N-terminal domain of one of the two RNA polymerase ǂ subunits 
(ǂNTD)(Hollands et al., 2010). 
In a similar manner to the CRP protein from E. coli, the M. tuberculosis CRP (Rickman et al., 
2005) is the best-studied example of a protein implicated in cAMP-mediated signaling. In M. 
tuberculosis CRP is encoded by the gene Rv3676 and it is homologous to E. coli CRP. In E. coli, 
it has been shown that CRP regulates expression of genes required to control metabolism, as 
well as growth under hypoxic and nutrient-deprived conditions. Like E. coli CRP, M. 
tuberculosis Rv3676 possesses an N-terminal cAMP-binding domain and a C-terminal DNA-
binding domain. The crystal structures of M. tuberculosis CRP at 2.2 and 2.0 A resolution of 
cAMP-bound (Reddy et al., 2009) and the apo-form (Gallagher et al., 2009), have been 
reported. Conformational changes required for DNA-binding do not take place in the 
absence of the second messenger (Reddy et al., 2009). In fact, as opposed to E. coli CRP 
where cAMP binding follows a cooperative mechanism, c-AMP binding sites are 
independent, and DNA-binding activity is not as enhanced with M. tuberculosis Rv3676 
(Stapleton et al., 2009). The CRP orthologous in M. bovis BCG (CRPBCG) is a fully functional 
transcription factor, since CRPBCG overcame the virulence deficiency of an M. tuberculosis crp 
mutant (Hunt et al., 2008). Although both of them have a similar ability to bind cAMP and 
DNA, CRPBCG’s DNA binding affinity is approximately twice that of Mycobacterium 
tuberculosis CRP (CRPMt) (Bai et al., 2007, Hunt et al., 2008). Interestingly, CRPBCG differs 
from CRPMt in just two amino acid residues (L47P and E178K).  
The other predicted cAMP-dependent transcriptional regulator, Cmr, was found to 
negatively regulate the expression of five proteins (GroEL2, Rv2971, PE_PGRS6a, Mdh 
and Rv1265) (Gazdik & McDonough, 2005). The upstream regions of three of these genes 
(mdh, groEL2 and Rv1265) bound specifically to Cmr in electrophoretic mobility shift 
assays, consistent with direct regulation of these genes by Cmr. Expression of three of 
these genes was found to be regulated within macrophages, and this regulation was 
mediated by Cmr in both M. tuberculosis and M. bovis BCG (Gazdik et al., 2009). Despite 
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the importance of Cmr for the cAMP- dependent regulation of these genes, Cmr has not 
been shown to directly bind cAMP in vitro, and cAMP did not affect Cmr’s binding to any 
of their promoter sequences (Gazdik et al., 2009). The mechanism by which Cmr responds 
to cAMP levels has yet to be discovered, and it is possible that a second factor plays a 
facilitating role. 
2.2 CRPMt regulon 
The cAMP binding transcriptional regulator encoded by Rv3676 in M. tuberculosis has been 
strongly associated with growth during mycobacterial life cycle. Its deletion resulted in 
impaired growth in macrophage cell lines and in mice (Hunt et al., 2008, Rickman et al., 
2005).  Using an exponential enrichment (SELEX) approach, Bai et al. defined the CRPMt´s 
palindromic binding motif (C/TGTGANNNNNNT CACG/A) based on 58 predicted 
binding sites from the M. tuberculosis genome, using a combination of E. coli CRP binding 
sites and M. tuberculosis DNA sequences recovered by affinity capture using CRPMt to seed 
the computational analyses (Bai et al., 2005). Akhter et al. used the positional Shannon 
relative entropy method to predict 19 new putative binding sites for M. tuberculosis (Rv3676) 
CRP, in addition to the 73 sites previously predicted by Bai et al. (Akhter et al., 2008, Bai et 
al., 2005). These additional sites resulted from a difference where Akhter et al. used only the 
information available from the M. tuberculosis CRP-regulon instead of adding up the one 
available from the E.coli CRP-regulon. According to Akhter et al., the M. tuberculosis CRP-
regulon comprises genes required for critical functions like: (i) cell-wall biogenesis, (ii) 
central metabolism pathways, (iii) putative regulatory elements controlling cAMP signaling, 
and (iv) antibiotic resistance (Akhter et al., 2008) (Table 2). 
Experimental validation of these predictions has only been completed for Bai et al. model 
(Bai et al., 2005). Their research showed that mutation of nucleotides G2 or C15 from the 
palindromic binding motif, abolished CRPMt´s binding. Both positions are conserved in all 
predicted binding sites. They also evaluated CRPMt and CRPBCG binding to seven putative 
CRPMt  sites, located within intergenic regions, where 6 out of these 7 were found to be 
functional in vitro and in vivo (Bai et al., 2007). This increases confidence in the prediction 
algorithm that was used to identify CRPMt binding sites, although at this point it is possible 
to suggest that CRPMt regulon requires further refinement. On the other hand, it has been 
shown that rpfA is directly activated by CRPMt (Rickman et al., 2005). The resuscitation-
promoting factor (Rpf) is a growth factor that stimulates the growth of aged M. tuberculosis 
cultures, and members of this family are thought to play a role in reactivation of dormant M. 
tuberculosis (Mukamolova et al., 2002). Regulation of rpfA by CRPMt suggests that CRPMt 
plays a role in persistence and/or reactivation of tuberculosis, but this is only one of many 
biological functions that may be regulated by CRPMt in M. tuberculosis.  
Expression of M. tuberculosis whiB1, a member of the Wbl (WhiB-like) family, is controlled 
positively and negatively by CRPMt (Stapleton et al., 2010; Agarwal et al., 2006). A CRPMt 
binding site (CRPMt1) was detected in whiB1’s upstream regulatory region (Smith et al., 2010) 
(Rickman et al., 2005). Reporter assays with native and mutated promoter sequences 
indicated that transcription from the native, but not the mutant, promoter was affected by 
cAMP levels via the direct binding with CRPMt (Agarwal et al., 2006). Other evidences 
indicate that a second CRPMt binding site (CRPMt2) in the whiB1 promoter altered CRPMt’s  
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Associated function Gene Predicted function 
 
 
Cell-wall biogenesis 
Rv0993 galU, uridine diphosphate-glucose 
pyrophosphorylase 
Rv3031 Members of the family of enzymes 
transferring activated sugars Rv3032
Rv0643c mma3, methoxy mycolic acid synthase 
Rv0904c AccD3, a putative acetyl CoA carboxylase 
carboxyl transferase, which catalyzes the 
initial steps of fatty acid and mycolic acid 
biosynthesis.  
 
 
 
Central metabolism 
pathways 
Rv2918 glnD, uridyl transferase
Rv0992c CHP with putative 5-formyltetrahydrofolate 
cyclo-ligase 
Rv0520 Methyl transferase believed to be involved in 
ubiquinone pathway
Rv3113 Phosphatase
Rv3114 Nucleoside deaminase
Rv3505 FadE27, protein possibly involved in 
regulating probable acyl-CoA dehydrogenase 
Rv3617 EphA, putative epoxide hydrolase 
 
Putative regulatory 
elements controlling 
cAMP signaling 
Rv0104 Hypothetical protein probably implied in 
cAMP mediated signaling in M. tuberculosis 
Rv0103c Probable cation transporter
Rv3645 Membrane linked adenylyl cyclase 
 
Antibiotic resistance 
Rv0906
Rv0907 Hypothetical proteins belonging to the  
-lactamase family
Rv0905 echA6, enoyl-CoA hydratase
Rv0908 CtpE, methyl-accepting chemotaxis protein 
Table 2. Mycobaterium genes belonging to CRP regulon and their associated function 
regulatory effect inhibiting whiB1 expression (Stapleton et al., 2010). Interestingly, only 
CRP1Mt enhances whiB1 expression, while CRP Mt 2 alone represses whiB1 expression. Dnase 
I footprinting assays allowed to determine the presence at −58.5 of an activating CRPMt 
binding site (CRP Mt 1), which matches in seven of the eight nucleotides from the proposed 
CRPMt consensus (NGTGNNANNNNNCACA), and also it overlapped with the repressing 
CRPMt binding site (CRP Mt 2) centred at −37.5. This second site has a poorer match to the 
consensus (six of the eight defined bases are matched)(Stapleton et al., 2010, Rickman et al., 
2005). CRP Mt 1 site was occupied before the CRPMt 2 site by a titration test done with 
increasing concentrations of CRPMt. It is worth noting that although it was shown that 
cAMP enhanced binding of recombinant CRPMt to target DNA, this enhancement was not 
equivalent to that observed for E. coli CRP, where DNA-binding affinity is enhanced by 
several orders of magnitude in the presence of 0.1 mM cAMP, allowing specific DNA 
binding at nanomolar concentrations. For CRPMt, a much less significant enhancement of 
DNA binding was observed, and higher concentrations of cAMP compared with E.coli CRP 
were required (Stapleton et al., 2010).  
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On the other hand, out of 92 genes found and predicted by bioinformatics to be regulated by 
CRP in M. tuberculosis, only 18 [including echA6, ctpE, accD3, sucC, sucD, glnD, fadE9, fbpC1 
(Ag85C) and galU] have conserved orthologous in M. leprae, M. avium subsp. 
paratuberculosis, and M. smegmatis (Akhter et al., 2008). Incorporation of a plasmid harboring 
and expressing M. tuberculosis Rv3676 in an M. tuberculosis strain in which Rv3676 was 
absent, induced differential expression of 27 genes when compared to the same mutant 
harboring the BCG gene orthologous to Rv3676 (Hunt et al., 2008). This constitutes evidence 
that differences in gene regulatory sequences or the regulators among species exist, and it 
could explain the number of genes that do not respond in a similar manner. Further 
characterization of the M. tuberculosis CRP regulon as well as analysis of what physiological 
conditions regulate activation/inactivation are required.  
3. Participation of cAMP in mycobacterial pathogenic processes 
Little is known about the role of cAMP in mycobacteria, although it is found in both 
pathogenic and non-pathogenic species. Ingestion of live M. microti or M. bovis BCG (but not 
M. lepraemurium) increased macrophage intracellular cAMP levels, whereas no change 
occurred in cells engulfing dead bacilli, latex beads or colloidal gold (Lowrie et al., 1979). 
The rise in cAMP levels appears directly related to mycobacterial capacity to interfere with 
phagolysosome formation, evidence suggesting that these microorganisms modify cAMP-
dependent signalling pathways as a manner to control virulence and infection (Lowrie et al., 
1975, Lowrie et al., 1979). Elevated cAMP levels were correlated with reduced 
phagolysosome fusion during mycobacterial infection of macrophages (Kalamidas et al., 
2006). Increased cAMP levels inside phagocytes were shown to negatively modulate actin-
dependent processes, including chemotactic movement and phagocytosis. Macrophage 
passage was found to have a stimulatory effect on cAMP production by mycobacteria, as 
cAMP levels within macrophage-passaged mycobacteria were ~50-fold higher than cAMP 
levels within bacteria incubated in the tissue culture medium alone (Bai et al., 2009). 
Evidences exist that cAMP regulates gene expression in mycobacteria during bacterial 
growth in vitro (Stapleton et al., 2010, Dass et al., 2008), and during macrophage infection 
(Rickman et al., 2005) where some studies identified Cmr as a transcription factor that 
regulates cAIGs (cAMP-iduced genes) within macrophages, and suggest that multiple 
factors affect cAMP-associated gene regulation in tuberculosis-complex mycobacteria 
(Gazdik et al., 2009). Even during phagocytosis, expression may be down regulated in 
response to high cAMP or NO levels inside the macrophage environment, providing a 
mechanism to integrate the transcriptional response to two important signals associated 
with infection (Smith et al., 2010). Generally, increases in cAMP levels compromise the 
bactericidal activity of the host immune system.  
It is likely that each cyclase is associated with a distinct signaling pathway. It is expected 
that specific cyclases are activated to modify cAMP levels in response to different 
physiological conditions as for example hypoxia, intramacrophage enviroment or pH 
changes. cAMP receptor protein (CRP) Rv3676 was found to exist as dimmer and exhibited 
cAMP binding in a concentration-dependent manner and could bind specifically to the 
putative CRP/FNR nucleotide sequence elements in response to hypoxia (Akhter et al., 
2008). The protein itself is composed of three distinct regions of the polypeptide: a large N-
terminal domain that binds cAMP, a long -helix (termed the C-helix) that mediates most of  
www.intechopen.com
 
Understanding Tuberculosis – Deciphering the Secret Life of the Bacilli 
 
112 
Gene Induction Repression
Rv0386 Palmitic acid 7H9 medium shaking
Tetracyclin Streptomyicin
Purified surfactant lipids
Rv0891c Oleic acid DETA/NO
Rv1120c Pulmonary surfactant Non-replicative persistence
Rv1264 Carbonyl cyanide chlorophenylhydrazone Palmitic acid
DETA/NO
Rv1318c Oligopeptide permease (Rv3662c-Rv3665c) mutant Pulmonary surfactant protein A (human)
Palmitic acid Acetate
Rv1319c Hypoxia Arachidonic acid
Hydrogen peroxide
Tioridazine
Nicotinamide
Rv1320c Acetate
Rv1359 Econazole Arachidonic acid
Macrophages Palmitic acid
Iron
Rv1625c Clofazimine + S-nitrosoglutathione Palmitic acid
Arachidonic acid Oleic acid
Thioridazine
Rv1647 Linoleic acid Streptomyicin
Palmitic acid Arachidonic acid
Oleic acid DETA/NO
Rv1900c Non-replicative persistence Tetracycline
PA 824 S-nitrosogluthatione + Chlorpromazine
Palmitic acid Acetate
Rv2212 Tetracycline 5-chloro-pyrazinamide
Rv2345 Starvation Thioridazine
DETA/NO
Rv2488c Arachidonic acid Tetracycline
Acetate Palmitic acid
Hydrogen peroxide
Rv3645 Oleic acid Oligopeptide permease (Rv3662c-Rv3665c) mutant
Acetate
Ceramide
 
Table 3. Growth conditions afecting expression of mycobacterial cyclase domain containing 
genes 
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the inter monomer interactions, and a small C-terminal DNA-binding domain. It is also 
capable of binding to two, three, or four cAMP molecules, but the specificity of recognition 
sequentially diminishes beyond two cAMP molecules bound to CRP, although the 
physiological importance of this molecular interactions are not yet known  (Stapleton et al., 
2010). Data available at Tuberculosis Database (http://www.tbdb.org/, Table 3) might help 
suggesting particular conditions where each AC gene may be required.  
Currently, few studies have addressed the participation of cAMP signalling in M. 
tuberculosis pathogenesis in vivo.  Rickman et al. (Rickman et al., 2005) found that a mutant in 
Rv3676 (CRP) had diminished bacterial burden in lung and spleen after intravenous 
infection of BALB/c mice, compared to wild type bacteria. On the other hand, Agarwal et al. 
(Agarwal et al., 2009) found that a Rv0386 M. tuberculosis mutant was affected in its capacity 
to replicate in BALB/c or C57BL/6 mice lungs, following aerosol infection. Neither 
publication mentioned the capacity of either strain to kill mice.  
In addition to determining bacterial burden in infected lungs Agarwal et al. (Agarwal et al., 
2009) demonstrated that cAMP produced by M. tuberculosis Rv0386 during J774.16 
macrophage infection was a substrate for protein kinase A, in order  to control the amount 
of phosphorylated CREB (CREB-P), by using specific chemical inhibitors of selected 
signalling transduction pathways. They found CREB-P induced TNF- production, and led 
to an unregulated host inflammatory response, which favoured bacterial survival. To date, 
this is the first indication of how adenylyl cyclase action helps sustaining an infection by 
pathogenic mycobacteria.  
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